Clinical Rheumatology

, Volume 16, Issue 1, pp 45–50 | Cite as

Characteristics of gouty arthritis in the guatemalan population

  • C. O. Garcia
  • A. G. Kutzbach
  • L. R. Espinoza


The purpose of this study was to determine the characteristics of gouty arthritis in an urban Guatemalan population. We reviewed the medical records of 148 (145 males and 3 females) patients with a diagnosis of acute gouty attack seen at an urban rheumatology clinic in Guatemala City between 1982 and 1993. Mean age at diagnosis was 49 years (range 21–87), mean age of onset was 42 years, mean duration of disease 7.4 years, family history of gout 42 (28%), peak prevalence 5th decade 39 (26%). Seventy-one (48%) had monarticular, 49 (33%) oligoarticular, and 22 (15%) polyarticular attacks, respectively. Podagra was seen in 34 (23%) patients; however, 108 (73%) developed it at any moment of their life. Tophaceous gout was seen in 33 (22%). Mean serum urate concentrations (enzymatic method) were higher than 7.0 mg % in 90 (60%) patients. At follow-up, 44 (30%) patients never returned to our clinic, and a large majority of them [66 (45%)] were seen only during acute attacks. Associated disorders included hypertension (43%), obesity (27%), nephrolithiasis (16%), ischaemic heart disease (7%), renal insufficiency (2%), stroke (0.6%), and diabetes mellitus (0.6%), and two died due to sepsis; high alcoholic intake was found in 58 (39%) patients. In conclusion, our findings indicate that gout is not an unusual disorder in the Guatemalan population. It presents with the same characteristics as those reported in Caucasians, with the possible exception of a lower frequency of diabetes mellitus as an associated disorder.

Key words

Gouty Arthritis Uric Acid Guatemalan Population 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Talbott JH, Yu TF. Gout and uric acid metabolism. Stration Intercontinental Medical Book Corp. 1976: 1–25.Google Scholar
  2. 2.
    Roubenoff R. Gout and hyperuricemia. In: Epidemiology of Rheumatic Diseases. Rheum Dis Clin North Am 1990; 16: 539–50.Google Scholar
  3. 3.
    Rose BS, Prior IAM, Davidson F. Gout and hyperuricemia in New Zealand and Polynesia. In: Population Studies of the Rheumatic Diseases. Eds.: Bennett, P.H., Wood, P.H.N. Amsterdam/New York: Excepta Medica 1968: 344–9.Google Scholar
  4. 4.
    Rose BS. Gout in the Maoris. Semin Arthritis Rheum 1975; 2: 121–45.Google Scholar
  5. 5.
    Darmawan J, Valkenburg HA, Muirden K, Wigley RD. The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol 1992; 19: 1595–99.Google Scholar
  6. 6.
    Hall AP, Barry PE, Dawboy TR, McNamara PM. Epidemiology of gout and hyperuricemia. Am J Med 1967; 42: 27–37.Google Scholar
  7. 7.
    Kellgren JH, Lawrence JS, Aitken-Swan J. Rheumatic complaints in an urban population. Ann Rheum Dis 1953; 12: 5–15.Google Scholar
  8. 8.
    Proper AJ, Hewit JV. Gout and hyperuricemia in rural and urban populations. Ann Rheum Dis 1962; 21: 154–67.Google Scholar
  9. 9.
    Fernandez del Vallado P, Jimenez C, Gijon J, Rapado A. La goutte fémenine. In: Seze S, ed. Travaux de Congrés International de la Goutte et de la Lithiase Urique. Evian, France: Presses du Val D'Osne: 1964: 75–84.Google Scholar
  10. 10.
    Grahame R, Scoot JT. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970; 29: 461–8.Google Scholar
  11. 11.
    Lou SF, Yu KH, Jan WU YJ, Ho HH. Clinical features of gout in 822 Chinese patients. Rev Esp Reum 1993; 20 We44 (suppl 1).Google Scholar
  12. 12.
    Pilipovic N. Clinical manifestations in 530 gout patients. Rev Esp Reum 1993; 20 We55 (suppl 1).Google Scholar
  13. 13.
    Nishioka N, Mikanag K. Clinical features of 4000 gouty subjects in Japan. In: Purine Metabolism in Man. Eds.: Rapado A, Watts RWE, De Bruyn CHMM. 3rd ed., New York, Plenum Press, 1980; 47–54.Google Scholar
  14. 14.
    Hadler NM, Frank WA, Bress NM, Robinson DR. Acute polyarticular gout. Am J Med 1974; 56: 715–9.Google Scholar
  15. 15.
    National Center for Health Statistics: Dawson DA, Adams PF. Current estimates from National Health Interview Survey, United States, 1986 Vital and Health Statistics, Series 10, No. 164 DHHS Pub No. (PHS)87-1592 Washington DC, US Gout. Printing Office, 1987.Google Scholar
  16. 16.
    Wallace SL, Robinson H, Masi AT, Decker JL, MaCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895–900.Google Scholar
  17. 17.
    1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evolution and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023–38.Google Scholar
  18. 18.
    National Diabetes Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–51.Google Scholar
  19. 19.
    Black D, James WPT, Besser GM, et al. Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 1983; 17: 5–65.Google Scholar
  20. 20.
    Nakayama DA, Barthelemy C, Carrera G, Lightfoot Jr, RW Wortmann RL. Tophaceous gout: A clinical and radiographic assessment. Arthritis Rheum 1984; 27: 468–72.Google Scholar
  21. 21.
    Dunn JP, Brooks GW, Mausner J, Rodnan GP. Social class gradient of serum uric acid levels in males. JAMA 1963; 185(3): 93–98.Google Scholar
  22. 22.
    Cobb S, Dunn JP, Brooks GW, Rodnan GP. Serum urate levels in males by social class. Arthritis Rheum 1961; 4: 412.Google Scholar
  23. 23.
    Lawrence RC, Hockborg MC, Kelsey JL, McDuffie FC, Medsger Jr TA, Felts WE, Shulman LE. Estimates of the prevalence of selected arthritis and musculoskeletal diseases in the United States. J Rheumatol 1989; 16: 427–41.Google Scholar
  24. 24.
    Mizraji M, Crespo DI. Chronic tophaceous gout of 51 years of duration. El Dia Medico Uruguayo 1955; 22: 635–40.Google Scholar
  25. 25.
    Moreno AR. Incidence of gout in Buenos Aires. Semin Hop Paris 1952; 28: 2369–75.Google Scholar
  26. 26.
    Lackington C. Incidencia relativa de las afecciones reumaticas. Analisis de 1,442 casos. Rev Med Chil 1972; 100: 564–71.Google Scholar
  27. 27.
    Mituszova M, Judat A, Poor G, Gyodi E, Stenszky V. Clinical and family studies in Hungarian patients with gout. Rheumatol Int 1992; 12: 165–8.Google Scholar
  28. 28.
    Alarcón-Segovia D, Ramos Miembro F, Gonzalez Amarro RF. One thousand private rheumatology patients in Mexico City. Arthritis Rheum 1983; 26: 688–89.Google Scholar
  29. 29.
    Cassim B, Mody GM, Deenadayalu VK, Hammond MG. Gout in black South Africans: a clinical and genetic study. Ann Rheum Dis 1994; 53: 759–62.Google Scholar
  30. 30.
    Yu TF. Some unusual features of gouty arthritis in females. Semin Arthritis Rheum 1977; 6: 247–55.Google Scholar
  31. 31.
    Turner RE, Frank MJ, Van Ausdal D, Bollet AJ. Some aspects of the epidemiology of gout: Sex and race incidence. Arch Int Med 1960; 106: 400–404.Google Scholar
  32. 32.
    Meyer OL, Monteagudo FSE. Gout in females: an analysis of 92 patients. Clin Exp Rheum 1985; 3: 105–9.Google Scholar
  33. 33.
    Levinson DJ, Becker MA. Clinical gout and the pathogenesis of hyperuricemia. In: Arthritis and Allied Conditions. Eds.: McCarty DJ, Koopman WJ. 12th ed. Lea & Febiger 1993; 2: 1773–1807.Google Scholar
  34. 34.
    Puig JG, Michan AD, Jimenez ML, Perez de Ayala C, Mateos FA, Capitan CF, Miguel E, Gijon JB. Female gout. Clinical spectrum and uric acid metabolism. Arch Int Med 1991; 151: 726–32.Google Scholar
  35. 35.
    Lally EW, Ho Jr G, Kaplan SR. The clinical spectrum of gouty arthritis in women. Arch Int Med 1986; 146: 2221–25.Google Scholar
  36. 36.
    Bosmansky K, Kovalancik M, Rovensky J, Pullman R. Analysis of clinical and biochemical finding in 371 patients with gout. Rev Esp Reum 1993; 20: We64 (suppl 1).Google Scholar
  37. 37.
    Frohlich ED. Uric acid. A risk factor for coronary heart disease. JAMA 1993; 270(3): 378–9.Google Scholar
  38. 38.
    Brand FN, Mcgee DL, Kanel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease. Am J Epidemiol 1985; 121: 11–8.Google Scholar
  39. 39.
    Weiss TE, Segaloff A, Moore C. Gout and diabetes. Metabolism 1957; 6: 103–6.Google Scholar
  40. 40.
    Gutman AB. Gout. In: Textbook of Medicine. 12th ed. Eds.: PB Beeson, W McDermontt. Philadelphia, WB Saunders Company 1967, pp 1238–48.Google Scholar
  41. 41.
    García CO, García-Kutzbach A, Espinoza LR. Gout in the Americas. Rev Bras Reum 1995; 35: 1–2.Google Scholar
  42. 42.
    Macfarlane DG, Dieppe PA. Diuretic-induced gout in elderly women. Br J Rheumatol 1985; 24: 155–7.Google Scholar

Copyright information

© Clinical Rheumatology 1997

Authors and Affiliations

  • C. O. Garcia
    • 2
  • A. G. Kutzbach
    • 1
  • L. R. Espinoza
    • 2
  1. 1.Guatemalan Association Against Rheumatic DiseasesFrancisco Marroquin UniversityGuatemala
  2. 2.Section of Rheumatology, Department of MedicineLSU Medical CenterNew OrleansUSA

Personalised recommendations